论文部分内容阅读
目的 探讨肺康复对慢性阻塞性肺疾病(COPD)患者的临床疗效.方法 选择2014年1月至2015年1月确诊COPD患者106例作为研究对象,随机分为空白对照组和肺康复计划组,空白对照组仅进行常规治疗,康复计划组在对照组治疗基础上进行肺康复,比较两组的肺通气功能、6 min步行试验(6MWD)和改良版英国医学研究委员会呼吸问卷(mMRC),明确肺康复的治疗时间.结果 治疗6周后,两组1 s用力呼气容积(FEV1)、FEV1/用力肺活量(FVC)、6MWD均有所升高,但以康复组升高幅度更加明显(P<0.05);mMRC评分均有所降低,但以康复组降低幅度更加明显(P<0.05).治疗12周后,康复组FEV1、FEV1/FVC、6MWD较治疗6周后又显著升高(P<0.05),mMRC评分显著降低(P<0.05).结论 肺康复可有效改善慢性阻塞性肺疾病患者的肺功能,减轻呼吸困难程度,提高运动耐力,且肺康复时间越长,效果越明显.“,”Objective To investigate the clinical effect of pulmonary rehabilitation on patients with chronic obstructive pulmonary (COPD) disease.Methods The 106 patients diagnosed as COPD from January 2014 to January 2015 were selected as the research objects, and they were randomly divided into blank control group and pulmonary rehabilitation program group.The blank control group only underwent conventional treatment, while the rehabilitation program group were given the pulmonary rehabilitation on the basis of the treatment of the blank control group.The pulmonary ventilation function, 6 minutes walk test (6MWD) and modified British Medical Research Council Respiratory Questionnaire (mMRC) were compared between the two groups, and the treatment time of pulmonary rehabilitation was defined.Results After 6 weeks of treatment, the FEV1, FEV1/FVC, and 6MWD in the two groups were increased, but the increase in the rehabilitation group was more significant (P<0.05);and the MMRC scores were decreased, but reduction in the rehabilitation group was more significant (P<0.05).After treatment for 12 weeks, the FEV1, FEV1/FVC, 6MWD in the rehabilitation group were significantly higher than those after treatment for 6 weeks (P<0.05), and the mMRC score was significantly lower (P<0.05).Conclusions The pulmonary rehabilitation can effectively improve the pulmonary function of patients with chronic obstructive pulmonary disease, reduce the degree of dyspnea, improve the exercise endurance, and pulmonary rehabilitation time is longer, the effect is more obvious.